Neuroscience
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-CD4 Reference Antibody (TRX1) | Login | Anti-CD4 Reference Antibody (TRX1) | ||||||||||||||||
|
||||||||||||||||||
| Anti-CD47 Reference Antibody (magrolimab) | Login | Anti-CD47 Reference Antibody (magrolimab) | ||||||||||||||||
|
||||||||||||||||||
| Anti-CD47 Reference Antibody (urabrelimab) | Login | Anti-CD47 Reference Antibody (urabrelimab) | ||||||||||||||||
|
||||||||||||||||||
| Anti-CD48 Reference Antibody (Regeneron patent anti-CD48) | Login | Anti-CD48 Reference Antibody (Regeneron patent anti-CD48) | ||||||||||||||||
|
||||||||||||||||||
| Anti-CDCP1 / CD318 Reference Antibody (U.California patent anti-CDCP1) | Login | Anti-CDCP1 / CD318 Reference Antibody (U.California patent anti-CDCP1) | ||||||||||||||||
|
||||||||||||||||||
| Anti-CLEC7A Reference Antibody (Baylor patent anti-Dectin-1) | Login | Anti-CLEC7A Reference Antibody (Baylor patent anti-Dectin-1) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Complement C5 Reference Antibody (crovalimab) | Login | Anti-Complement C5 Reference Antibody (crovalimab) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Complement C5 Reference Antibody (lendalizumab) | Login | Anti-Complement C5 Reference Antibody (lendalizumab) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Complement C5 Reference Antibody (pozelimab) | Login | Anti-Complement C5 Reference Antibody (pozelimab) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Complement C5 Reference Antibody (vilobelimab) | Login | Anti-Complement C5 Reference Antibody (vilobelimab) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Complement C5aR1 Reference Antibody (G2 patent anti-C5aR) | Login | Anti-Complement C5aR1 Reference Antibody (G2 patent anti-C5aR) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Complement C5aR1 Reference Antibody (G2_anti-C5aR) | Login | Anti-Complement C5aR1 Reference Antibody (G2_anti-C5aR) | ||||||||||||||||
|
||||||||||||||||||
| Anti-CRTAM / CD355 Reference Antibody (Oxford Bio patent anti-CRTAM) | Login | Anti-CRTAM / CD355 Reference Antibody (Oxford Bio patent anti-CRTAM) | ||||||||||||||||
|
||||||||||||||||||
| Anti-CXADR Reference Antibody (Med. Bio. Labs patent anti-CXADR) | Login | Anti-CXADR Reference Antibody (Med. Bio. Labs patent anti-CXADR) | ||||||||||||||||
|
||||||||||||||||||
| Anti-EMMPRIN / CD147 Reference Antibody (Centocor patent anti-CD147) | Login | Anti-EMMPRIN / CD147 Reference Antibody (Centocor patent anti-CD147) | ||||||||||||||||
|
||||||||||||||||||
| Anti-EphA2 Reference Antibody (Sanofi Aventis patent anti-EphA2) | Login | Anti-EphA2 Reference Antibody (Sanofi Aventis patent anti-EphA2) | ||||||||||||||||
|
||||||||||||||||||
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (7A7) | Login | Anti-ERBB1 / EGFR / HER1 Reference Antibody (7A7) | ||||||||||||||||
|
||||||||||||||||||
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (depatuxizumab-MMAF) | Login | Anti-ERBB1 / EGFR / HER1 Reference Antibody (depatuxizumab-MMAF) | ||||||||||||||||
|
||||||||||||||||||
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (Duke D2C7) | Login | Anti-ERBB1 / EGFR / HER1 Reference Antibody (Duke D2C7) | ||||||||||||||||
|
||||||||||||||||||
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (Regeneron patent anti-EGFR) | Login | Anti-ERBB1 / EGFR / HER1 Reference Antibody (Regeneron patent anti-EGFR) | ||||||||||||||||
|
||||||||||||||||||
| Anti-ERBB1 / EGFR / HER1 Reference Antibody (Shanghai Cancer Inst patent anti-EGFRvIII) | Login | Anti-ERBB1 / EGFR / HER1 Reference Antibody (Shanghai Cancer Inst patent anti-EGFRvIII) | ||||||||||||||||
|
||||||||||||||||||
| Anti-ERBB2 / HER2 / CD340 Reference Antibody (BioMab patent anti-Her2) | Login | Anti-ERBB2 / HER2 / CD340 Reference Antibody (BioMab patent anti-Her2) | ||||||||||||||||
|
||||||||||||||||||
| Anti-ERBB2 / HER2 / CD340 Reference Antibody (coprelotamab) | Login | Anti-ERBB2 / HER2 / CD340 Reference Antibody (coprelotamab) | ||||||||||||||||
|
||||||||||||||||||
| Anti-ERBB2 / HER2 / CD340 Reference Antibody (Hersintuzumab) | Login | Anti-ERBB2 / HER2 / CD340 Reference Antibody (Hersintuzumab) | ||||||||||||||||
|
||||||||||||||||||
| Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab emtansine) | Login | Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab emtansine) | ||||||||||||||||
|
||||||||||||||||||


